TLC C-53 liposomal prostaglandin E1: Completed Phase I/II placebo-controlled trial in 25 patients. Results will be presented Feb. 3 at the Society of Critical C

The Liposome Co. Inc. (LIPO) Product: TLC C-53 liposomal prostaglandin E1 Indication: Acute respiratory distress syndrome Status: Completed Phase I/II placebo-controlled trial in 25 patients. Results ...